Crohn's disease

• An open label, balanced, randomized, two-treatment, four period, two-sequence, multiple-dose (steady-state), fully-replicate crossover bioeq … Ended
  2024-512770-10-00 2 2024-10-07 "Rheumatoid arthritis, ulcerative colitis, atopic dermatitis,"
• An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci … Ended
  2024-512771-12-00 2 2024-09-17 "Axial spondyloarthritis"
• An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci … Ended
  2024-512773-27-00 2 2024-08-19 "Rheumatoid arthritis, ulcerative colitis, atopic dermatitis,"
• PASSPORT Ended
  2023-508584-72-00 5 2024-07-10 "Immune Bowel Disease (including Crohn's disease and Ulcerati"
• Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod in Pediatric Participants with Moderately to Severely Active Crohn … Ended
  2023-508777-91-00 10 2023-05-16 "Moderately to Severely Active Crohn's Disease"
• A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended
  2022-502872-22-00 3 2023-04-28 "Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcerative "
• A Phase 1 Study to Evaluate the Safety and Target Engagement of EXL01 in the Maintenance of Steroid-induced Clinical Response or Remission … Ended
  2022-502241-99-00 1 2023-03-20 "Crohn's Disease"
• A phase IIa, open label, Single-centre study to assess the initial antifibrotic efficacy, safety, tolerability, pharmacokinetic and pharmaco … Ended
  2022-501464-18-00 4 2023-03-01 "Crohn’s disease"
• A study to test whether BI 706321 combined with ustekinumab helps people with Crohn's Disease Ended
  2024-512756-38-00 4 2022-02-17 "Crohn`s Disease (CD)"
• A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan … Ended
  2024-513569-38-00 10 2021-07-09 "Crohn's Disease"
• Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Induction Treatment Followed by Subcutaneous Ustek … Ended
  2023-504978-38-00 5 2021-03-16 "Moderately to Severely Active Crohn's Disease"
• Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease Ended
  2024-511553-22-00 5 2018-10-05 "Moderately to Severely Active Crohn's Disease"
• Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease Ended
  2023-510426-33-00 5 2018-09-27 "Moderately to Severely Active Crohn's Disease"
• An extension study to investigate how safe Vedolizumab is in child patients with Ulcerative Colitis or Crohn's Disease Ended
  2023-507766-35-00 4 2018-01-09 "Ulcerative Colitis or Crohn's Disease"

Showing 49–62 of 62 trials